Home » Stocks » PURE Bioscience

PURE Bioscience Inc. (PURE)

Stock Price: $1.49 USD -0.01 (-0.67%)
Updated Aug 6, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 129.47M
Revenue (ttm) 3.58M
Net Income (ttm) -2.14M
Shares Out 86.89M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $1.49
Previous Close $1.50
Change ($) -0.01
Change (%) -0.67%
Day's Open 1.50
Day's Range 1.48 - 1.50
Day's Volume 95,914
52-Week Range 0.20 - 2.05

More Stats

Market Cap 129.47M
Enterprise Value 127.37M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 86.89M
Float 57.62M
EPS (basic) -0.02
EPS (diluted) -0.03
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 222,969
Short Ratio 2.56
Short % of Float 1.86%
Beta 0.16
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 36.15
PB Ratio 37.71
Revenue 3.58M
Operating Income -2.14M
Net Income -2.14M
Free Cash Flow -1.86M
Net Cash 2.10M
Net Cash / Share 0.02
Gross Margin 32.98%
Operating Margin -59.79%
Profit Margin -59.70%
FCF Margin -52.02%
ROA -41.20%
ROE -95.51%
ROIC -1,111.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $1.49
Target: 24.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth7.61%-3.11%42.05%76.82%32.55%-32.93%0.99%75%-67.69%-
Gross Profit1.
Operating Income-5.59-7.04-6.01-7.06-7.64-11.90-7.34-8.75-8.37-6.91
Net Income-6.55-7.44-6.26-14.37-7.63-11.05-7.67-8.89-8.35-6.76
Shares Outstanding72.8867.2863.4956.8339.7525.6110.845.624.674.32
Earnings Per Share-0.09-0.11-0.10-0.25-0.19-0.43-0.71-1.58-1.79-1.60
Operating Cash Flow-2.99-3.89-4.56-4.99-6.06-6.33-3.90-5.59-6.12-5.52
Capital Expenditures-0.01-0.02-0.21-0.39-0.080.05-0.01-0.01-0.01-0.22
Free Cash Flow-3.00-3.91-4.77-5.38-6.14-6.28-3.92-5.60-6.14-5.75
Cash & Equivalents0.470.931.725.271.400.090.030.881.792.19
Total Debt-0.50----1.26---
Net Cash / Debt0.470.421.725.271.400.09-1.220.881.792.19
Book Value1.
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PURE Bioscience Inc.
Country United States
Employees 10
CEO Tom Y. Lee

Stock Information

Ticker Symbol PURE
Stock Exchange US OTC
Sector Consumer Defensive
Industry Household & Personal Products
Unique Identifier OTCMKTS: PURE
IPO Date August 8, 1996


PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate that is used to clean stainless steel equipment, resilient floors, walls, and painted surfaces. Its SDC-based disinfecting and sanitizing products comprise Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial solution that is used against bacteria, viruses, yeasts, and molds. The company was founded in 1992 and is headquartered in Rancho Cucamonga, California.